Article Details

Botanix Pharmaceuticals (ASX:BOT) receives encouraging results from canine study

Retrieved on: 2021-05-17 00:56:15

Tags for this article:

Click the tags to see associated articles and topics

Botanix Pharmaceuticals (ASX:BOT) receives encouraging results from canine study. View article details on hiswai:

Excerpt

Health Care · ASX:BOT MCAP $75.90M. Julia Seymour julia.seymour@themarketherald.com ...

Article found on: themarketherald.com.au

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up